Home > > > Report Detail

Global Companion Diagnostics (CDx) Development Services Market Research Report 2023

Publisher Name :
Date: 26-Jan-2023
No. of pages: 99
Inquire Before Buying

Highlights

The global Companion Diagnostics (CDx) Development Services market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Companion Diagnostics (CDx) Development Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Companion Diagnostics (CDx) Development Services is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Companion Diagnostics (CDx) Development Services in Infectious Diseases is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Companion Diagnostics (CDx) Development Services include Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, Quest Diagnostics, Q² Solutions, ResearchDx, Almac Diagnostic Services, Biocartis and Cerba Research, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Companion Diagnostics (CDx) Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostics (CDx) Development Services.

The Companion Diagnostics (CDx) Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Companion Diagnostics (CDx) Development Services market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Companion Diagnostics (CDx) Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Geneuity-Clinical Research Services

- Interpace Biosciences

- Labcorp

- Quest Diagnostics

- Q² Solutions

- ResearchDx

- Almac Diagnostic Services

- Biocartis

- Cerba Research

- Eurofins Scientific

- MLM Medical Labs

- Qiagen

- BGI Genomics

- MEDx Translational Medicine

- Medical Biological Laboratories (MBL)

- Novogene

Segment by Type

- Feasibility Studies

- Assay Development

- Analytical Validation

- Clinical Validation

- Others

Segment by Application

- Infectious Diseases

- Neurological Disorders

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Companion Diagnostics (CDx) Development Services companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Companion Diagnostics (CDx) Development Services Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Feasibility Studies
1.2.3 Assay Development
1.2.4 Analytical Validation
1.2.5 Clinical Validation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Companion Diagnostics (CDx) Development Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infectious Diseases
1.3.3 Neurological Disorders
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostics (CDx) Development Services Market Perspective (2018-2029)
2.2 Companion Diagnostics (CDx) Development Services Growth Trends by Region
2.2.1 Global Companion Diagnostics (CDx) Development Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Companion Diagnostics (CDx) Development Services Historic Market Size by Region (2018-2023)
2.2.3 Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2024-2029)
2.3 Companion Diagnostics (CDx) Development Services Market Dynamics
2.3.1 Companion Diagnostics (CDx) Development Services Industry Trends
2.3.2 Companion Diagnostics (CDx) Development Services Market Drivers
2.3.3 Companion Diagnostics (CDx) Development Services Market Challenges
2.3.4 Companion Diagnostics (CDx) Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue
3.1.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue (2018-2023)
3.1.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Companion Diagnostics (CDx) Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostics (CDx) Development Services Revenue
3.4 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio
3.4.1 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics (CDx) Development Services Revenue in 2022
3.5 Companion Diagnostics (CDx) Development Services Key Players Head office and Area Served
3.6 Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service
3.7 Date of Enter into Companion Diagnostics (CDx) Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostics (CDx) Development Services Breakdown Data by Type
4.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Type (2018-2023)
4.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2024-2029)
5 Companion Diagnostics (CDx) Development Services Breakdown Data by Application
5.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Application (2018-2023)
5.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
6.2 North America Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023)
6.4 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
7.2 Europe Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023)
7.4 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
8.2 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
9.2 Latin America Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023)
9.4 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size (2018-2029)
10.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Geneuity-Clinical Research Services
11.1.1 Geneuity-Clinical Research Services Company Detail
11.1.2 Geneuity-Clinical Research Services Business Overview
11.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Introduction
11.1.4 Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.1.5 Geneuity-Clinical Research Services Recent Development
11.2 Interpace Biosciences
11.2.1 Interpace Biosciences Company Detail
11.2.2 Interpace Biosciences Business Overview
11.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Introduction
11.2.4 Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.2.5 Interpace Biosciences Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Detail
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Companion Diagnostics (CDx) Development Services Introduction
11.3.4 Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.3.5 Labcorp Recent Development
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Detail
11.4.2 Quest Diagnostics Business Overview
11.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Introduction
11.4.4 Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.4.5 Quest Diagnostics Recent Development
11.5 Q² Solutions
11.5.1 Q² Solutions Company Detail
11.5.2 Q² Solutions Business Overview
11.5.3 Q² Solutions Companion Diagnostics (CDx) Development Services Introduction
11.5.4 Q² Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.5.5 Q² Solutions Recent Development
11.6 ResearchDx
11.6.1 ResearchDx Company Detail
11.6.2 ResearchDx Business Overview
11.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Introduction
11.6.4 ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.6.5 ResearchDx Recent Development
11.7 Almac Diagnostic Services
11.7.1 Almac Diagnostic Services Company Detail
11.7.2 Almac Diagnostic Services Business Overview
11.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Introduction
11.7.4 Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.7.5 Almac Diagnostic Services Recent Development
11.8 Biocartis
11.8.1 Biocartis Company Detail
11.8.2 Biocartis Business Overview
11.8.3 Biocartis Companion Diagnostics (CDx) Development Services Introduction
11.8.4 Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.8.5 Biocartis Recent Development
11.9 Cerba Research
11.9.1 Cerba Research Company Detail
11.9.2 Cerba Research Business Overview
11.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Introduction
11.9.4 Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.9.5 Cerba Research Recent Development
11.10 Eurofins Scientific
11.10.1 Eurofins Scientific Company Detail
11.10.2 Eurofins Scientific Business Overview
11.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Introduction
11.10.4 Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.10.5 Eurofins Scientific Recent Development
11.11 MLM Medical Labs
11.11.1 MLM Medical Labs Company Detail
11.11.2 MLM Medical Labs Business Overview
11.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Introduction
11.11.4 MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.11.5 MLM Medical Labs Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Detail
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Companion Diagnostics (CDx) Development Services Introduction
11.12.4 Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.12.5 Qiagen Recent Development
11.13 BGI Genomics
11.13.1 BGI Genomics Company Detail
11.13.2 BGI Genomics Business Overview
11.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Introduction
11.13.4 BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.13.5 BGI Genomics Recent Development
11.14 MEDx Translational Medicine
11.14.1 MEDx Translational Medicine Company Detail
11.14.2 MEDx Translational Medicine Business Overview
11.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Introduction
11.14.4 MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.14.5 MEDx Translational Medicine Recent Development
11.15 Medical Biological Laboratories (MBL)
11.15.1 Medical Biological Laboratories (MBL) Company Detail
11.15.2 Medical Biological Laboratories (MBL) Business Overview
11.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Introduction
11.15.4 Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.15.5 Medical Biological Laboratories (MBL) Recent Development
11.16 Novogene
11.16.1 Novogene Company Detail
11.16.2 Novogene Business Overview
11.16.3 Novogene Companion Diagnostics (CDx) Development Services Introduction
11.16.4 Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023)
11.16.5 Novogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Feasibility Studies
Table 3. Key Players of Assay Development
Table 4. Key Players of Analytical Validation
Table 5. Key Players of Clinical Validation
Table 6. Key Players of Others
Table 7. Global Companion Diagnostics (CDx) Development Services Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Companion Diagnostics (CDx) Development Services Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2018-2023)
Table 11. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2024-2029)
Table 13. Companion Diagnostics (CDx) Development Services Market Trends
Table 14. Companion Diagnostics (CDx) Development Services Market Drivers
Table 15. Companion Diagnostics (CDx) Development Services Market Challenges
Table 16. Companion Diagnostics (CDx) Development Services Market Restraints
Table 17. Global Companion Diagnostics (CDx) Development Services Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Companion Diagnostics (CDx) Development Services Market Share by Players (2018-2023)
Table 19. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2022)
Table 20. Ranking of Global Top Companion Diagnostics (CDx) Development Services Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Companion Diagnostics (CDx) Development Services Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service
Table 24. Date of Enter into Companion Diagnostics (CDx) Development Services Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Companion Diagnostics (CDx) Development Services Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2018-2023)
Table 28. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2024-2029)
Table 30. Global Companion Diagnostics (CDx) Development Services Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2018-2023)
Table 32. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2024-2029)
Table 34. North America Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2024-2029) & (US$ Million)
Table 49. Geneuity-Clinical Research Services Company Detail
Table 50. Geneuity-Clinical Research Services Business Overview
Table 51. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product
Table 52. Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 53. Geneuity-Clinical Research Services Recent Development
Table 54. Interpace Biosciences Company Detail
Table 55. Interpace Biosciences Business Overview
Table 56. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product
Table 57. Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 58. Interpace Biosciences Recent Development
Table 59. Labcorp Company Detail
Table 60. Labcorp Business Overview
Table 61. Labcorp Companion Diagnostics (CDx) Development Services Product
Table 62. Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 63. Labcorp Recent Development
Table 64. Quest Diagnostics Company Detail
Table 65. Quest Diagnostics Business Overview
Table 66. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product
Table 67. Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 68. Quest Diagnostics Recent Development
Table 69. Q² Solutions Company Detail
Table 70. Q² Solutions Business Overview
Table 71. Q² Solutions Companion Diagnostics (CDx) Development Services Product
Table 72. Q² Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 73. Q² Solutions Recent Development
Table 74. ResearchDx Company Detail
Table 75. ResearchDx Business Overview
Table 76. ResearchDx Companion Diagnostics (CDx) Development Services Product
Table 77. ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 78. ResearchDx Recent Development
Table 79. Almac Diagnostic Services Company Detail
Table 80. Almac Diagnostic Services Business Overview
Table 81. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product
Table 82. Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 83. Almac Diagnostic Services Recent Development
Table 84. Biocartis Company Detail
Table 85. Biocartis Business Overview
Table 86. Biocartis Companion Diagnostics (CDx) Development Services Product
Table 87. Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 88. Biocartis Recent Development
Table 89. Cerba Research Company Detail
Table 90. Cerba Research Business Overview
Table 91. Cerba Research Companion Diagnostics (CDx) Development Services Product
Table 92. Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 93. Cerba Research Recent Development
Table 94. Eurofins Scientific Company Detail
Table 95. Eurofins Scientific Business Overview
Table 96. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product
Table 97. Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 98. Eurofins Scientific Recent Development
Table 99. MLM Medical Labs Company Detail
Table 100. MLM Medical Labs Business Overview
Table 101. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product
Table 102. MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 103. MLM Medical Labs Recent Development
Table 104. Qiagen Company Detail
Table 105. Qiagen Business Overview
Table 106. Qiagen Companion Diagnostics (CDx) Development Services Product
Table 107. Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 108. Qiagen Recent Development
Table 109. BGI Genomics Company Detail
Table 110. BGI Genomics Business Overview
Table 111. BGI Genomics Companion Diagnostics (CDx) Development Services Product
Table 112. BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 113. BGI Genomics Recent Development
Table 114. MEDx Translational Medicine Company Detail
Table 115. MEDx Translational Medicine Business Overview
Table 116. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product
Table 117. MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 118. MEDx Translational Medicine Recent Development
Table 119. Medical Biological Laboratories (MBL) Company Detail
Table 120. Medical Biological Laboratories (MBL) Business Overview
Table 121. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product
Table 122. Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 123. Medical Biological Laboratories (MBL) Recent Development
Table 124. Novogene Company Detail
Table 125. Novogene Business Overview
Table 126. Novogene Companion Diagnostics (CDx) Development Services Product
Table 127. Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2018-2023) & (US$ Million)
Table 128. Novogene Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostics (CDx) Development Services Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Companion Diagnostics (CDx) Development Services Market Share by Type: 2022 VS 2029
Figure 3. Feasibility Studies Features
Figure 4. Assay Development Features
Figure 5. Analytical Validation Features
Figure 6. Clinical Validation Features
Figure 7. Others Features
Figure 8. Global Companion Diagnostics (CDx) Development Services Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Companion Diagnostics (CDx) Development Services Market Share by Application: 2022 VS 2029
Figure 10. Infectious Diseases Case Studies
Figure 11. Neurological Disorders Case Studies
Figure 12. Companion Diagnostics (CDx) Development Services Report Years Considered
Figure 13. Global Companion Diagnostics (CDx) Development Services Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Companion Diagnostics (CDx) Development Services Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Companion Diagnostics (CDx) Development Services Market Share by Region: 2022 VS 2029
Figure 16. Global Companion Diagnostics (CDx) Development Services Market Share by Players in 2022
Figure 17. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostics (CDx) Development Services Revenue in 2022
Figure 19. North America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Companion Diagnostics (CDx) Development Services Market Share by Country (2018-2029)
Figure 21. United States Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Companion Diagnostics (CDx) Development Services Market Share by Country (2018-2029)
Figure 25. Germany Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Share by Region (2018-2029)
Figure 33. China Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Companion Diagnostics (CDx) Development Services Market Share by Country (2018-2029)
Figure 41. Mexico Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Share by Country (2018-2029)
Figure 45. Turkey Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Geneuity-Clinical Research Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 48. Interpace Biosciences Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 49. Labcorp Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 50. Quest Diagnostics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 51. Q² Solutions Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 52. ResearchDx Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 53. Almac Diagnostic Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 54. Biocartis Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 55. Cerba Research Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 56. Eurofins Scientific Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 57. MLM Medical Labs Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 58. Qiagen Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 59. BGI Genomics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 60. MEDx Translational Medicine Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 61. Medical Biological Laboratories (MBL) Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 62. Novogene Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs